|
|
Volumn 21, Issue , 2003, Pages 235-258
|
|
Rituximab.
a
a
BIOGEN
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
RITUXIMAB;
CLASSIFICATION;
CLINICAL TRIAL;
HUMAN;
LYMPHOMA;
PATHOLOGY;
REVIEW;
SAFETY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
HUMANS;
LYMPHOMA;
SAFETY;
MLCS;
MLOWN;
|
|
EID: 4444328362
PISSN: 09214410
EISSN: None
Source Type: Journal
DOI: 10.1016/s0921-4410(03)21011-5 Document Type: Review |
|
Times cited : (4)
|
|
References (138)
|
